Brazil is in the process of operationalizing the National System of Drug Control (SNCM). The project provides for a two-dimensional bar code on packaging that will allow monitoring the trajectory of medicines from the ex-factory to the pharmacy counter. Information such as batch, date, serial number and registration number in Anvisa will be gathered in the Drug Unique Identifier (IUM).
From the management point of view the supply chain, the improvement is evident. Ensures the authenticity and legal validity of the drug, avoiding deviations in the supply chain and allowing faster action of health monitoring. If there is a need for product pickup, either by quality problems or need for surveillance intervention, the system will speed the recall process, preventing the arrival of the product to the consumer.
Want to know how to São Camilo Network secured an integrated management of your units?
Watch the video and check out the testimony of the Network IT director of St. Camillus Hospital of São Paulo, Klaiton Simon, and check out how Information Technology is used in the institution not just to record data and monitor billing, but rather for differential competitivo.Assista video
The system is also advantageous for the sector of pharmaceutical care as a whole. IUM allows a remedy to curb the theft of cargo, combat fraud, smuggling and counterfeiting. Currently, the sale of counterfeit products, including medicines, causes losses of over R $ 30 billion a year to the country. The cargo theft is another serious problem. In 2014, for example, Anvisa was notified of more than 1,200 load stolen or lost drugs.
And automates all stages of the logistics process, traceability also brings benefits to the industry with the most effective risk management in the supply chain, avoiding mistakes and losses maturities. The new capacity management on the drug surveillance system promoted by the law can improve processes, controls and thereby reduce costs.
The implementation of SNCM and technologies for traceability aims to ensure security of patients and professionals and, above all, quality improvement in service delivery. As for the productive sector, the benefits range from the effective control of production and logistics costs, the flows of facilities to maintain regulatory compliance standards.